To begin to investigate if KIF11 inhibition was capable of radiosensitizing GBM cells, we utilized clonogenic assays to quantify reproductive cell survival after irradiation as this approach is associated with the clinical response of a tumor to radiotherapy [31,32,33,34]. The gene discussed is KIF11; the disease is glioblastoma.